Cholera vaccine CVD 110 - Berna BiotechAlternative Names: CVD 110
Latest Information Update: 26 Jul 1994
At a glance
- Originator Berna Biotech; Nonindustrial source
- Class Cholera vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cholera
Most Recent Events
- 22 Dec 1993 Discontinued-I for Cholera in USA (PO)
- 22 Dec 1993 Discontinued-I for Cholera in Switzerland (PO)